FDA Approves Unknown Drug — OZANTRI

OZANTRI has solidified its market position in the pharmaceutical sector following the FDA's confirmation of its regulatory status via the benchmark ANDA 085106 filing, a move that validates the company's commercial standing and operational compliance.